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Scott T. Barrett and Rick A. Bevins
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Abstract
Reward enhancement by nicotine has been suggested as an important phenomenon contributing
toward tobacco abuse and dependence. Reinforcement value is a multifaceted construct not fully
represented by any single measure of response strength. The present study evaluated the changes
in the reinforcement value of a visual stimulus in 16 male Sprague–Dawley rats using the
reinforcer demand technique proposed by Hursh and Silberberg. The different parameters of the
model have been shown to represent differing facets of reinforcement value, including intensity,
perseverance, and sensitivity to changes in response cost. Rats lever-pressed for 1-min
presentations of a compound visual stimulus over blocks of 10 sessions across a range of response
requirements (fixed ratio 1, 2, 4, 8, 14, 22, 32). Nicotine (0.4 mg/kg, base) or saline was
administered 5 min before each session. Estimates from the demand model were calculated
between nicotine and saline administration conditions within subjects and changes in
reinforcement value were assessed as differences in Q0, Pmax, Omax, and essential value. Nicotine
administration increased operant responding across the entire range of reinforcement schedules
tested, and uniformly affected model parameter estimates in a manner suggesting increased
reinforcement value of the visual stimulus.
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Introduction
Tobacco use is the leading cause of preventable death and disease worldwide, making it the
largest single contributor to the global burden of disease (World Health Organization, 2004).
The rewarding effects of nicotine are commonly accepted as the principal driving
mechanism responsible for tobacco addiction (United States Department of Health and
Human Services, 1988). The role of nicotine and reward in establishing and maintaining
tobacco dependence is commonly conceptualized in three ways: (a) nicotine is a primary
reinforcer, possessing inherent rewarding properties of its own that influence behavior
(Corrigall and Coen, 1989; Donny et al., 1998); (b) nicotine-associated stimuli acquire
conditioned rewarding properties by virtue of their association with the rewarding effects of
nicotine, and these also influence behavior (Rose et al., 2000; Caggiula et al., 2001;
Wilkinson and Bevins, 2008); and (c) nicotine functions as a reward-enhancer, increasing
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the reinforcement value of other rewarding stimuli in its presence (Donny et al., 2003;
Bevins and Palmatier, 2004; Chaudhri et al., 2006a, 2006b; Caggiula et al., 2009).
All three of these facets are important in understanding the nature of nicotine reward and
tobacco dependence. However, the reward-enhancing effects of nicotine have received
considerable attention recently as it appears to fill a gap in our current understanding of
tobacco dependence. Namely, a growing body of evidence suggests that the primary
reinforcing effects of nicotine and associated conditioned reward it imbues to environmental
stimuli cannot account for the entirety of tobacco dependence (Donny et al., 2003; Chaudhri
et al., 2006a, 2006b; Palmatier et al., 2006). Recent studies on the role of nicotine in tobacco
addiction have shown that nicotine also has robust reinforcement-enhancing properties.
Briefly, in a study by Donny et al. (2003) using the nicotine self-administration procedure,
rats were trained to press a lever to receive infusions of 0.03 mg/kg nicotine or of 0.9%
saline. Some of these rats received infusions coupled with the presentation of a 1-min visual
stimulus (VS), whereas the remaining rats received infusions without any other
consequence. Additional groups of rats were allowed to press the active lever for the VS
only, and received either nicotine or saline infusions independent of their lever pressing.
Active lever response rates were significantly elevated in rats receiving nicotine infusions
and the VS, irrespective of whether or not nicotine delivery was contingent upon their
behavior. This finding has now been replicated in several studies, using a variety of different
procedures and routes of nicotine administration (e.g. Chaudhri et al., 2006a, 2006b;
Palmatier et al., 2006; Raiff and Dallery, 2006, 2009; Caggiula et al., 2009).
The finding that nicotine leads to an increase in response rates for a VS in rats has been
interpreted as an inherent ability of nicotine to increase the reinforcing effectiveness of other
stimuli (Chaudhri et al., 2006a, 2006b; Caggiula et al., 2009). There is good reason to accept
this conclusion, as response rate is a well documented and widely used measure of
reinforcement value and response strength (Skinner, 1938; Killeen and Hall, 2001; Hursh
and Silberberg, 2008). However, response rate is only one of several putative measures of
reinforcement value. A large body of literature has repeatedly shown that various accepted
measures of reinforcement value often lead to conflicting conclusions about the strength of a
given response (Herrnstein, 1961, 1970; Nevin, 1974, 1995; Killeen and Hall, 2001; Hursh
and Silberberg, 2008). Unfortunately, little attention has been paid to the application of
different measures of response strength to the reinforcement-enhancing effects of nicotine
(but see Cassidy and Dallery, 2012).
An increasingly popular method of analyzing the reinforcement value of a wide variety of
rewards relies on the application of economic demand models to the operant behavior of
animals (Hursh, 1980, 1993; Hursh and Silberberg, 2008). This approach generally involves
training subjects to respond for a putative reinforcer over several blocks of sessions,
between which the response requirement per reinforcer delivery (unit cost) is varied. Once
subjects have experienced all test conditions of interest, the data are analyzed and demand
curves are generated by applying the following mathematical model:
(1)
where Q represents units of consumption, Q0 represents units of consumption at the lowest
price of the demand curve, C represents the cost requirement [fixed-ratio (FR) value], k is a
constant that specifies the number of log units spanned by the demand curve, e represents
the base of the natural logarithm, and a is a free parameter that is adjusted to minimize the
differences between the predictions of the equation and the demand curve to which it is
being fit. The a value is of particular interest as it represents the rate of change in elasticity
of demand and thus provides a simple index of essential value (a component of
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reinforcement value independent of magnitude; see Hursh and Winger, 1995; Hursh and
Silberberg, 2008). In addition, the measures of Pmax and Omax, which represent the unit cost
of unitary elasticity (where the curve shifts from inelastic to elastic), and the level of
maximal behavioral output, respectively, are also derived from the predictions of the model.
The benefit of such an approach is the ability to assess the value of a reinforcer across a
variety of response requirements, instead of a single unit cost, yielding a more
comprehensive assessment of the strength of a reinforcer. Furthermore, many of the
parameters and derivations of the model serve as reliable indices that may represent different
facets of reinforcer value as a construct. Specifically, the values of Q0, Pmax, Omax, and a
may be believed to, respectively, represent the intensity of demand for the reinforcer,
perseverance of responding for the reinforcer in the face of fluctuations in price, maximal
behavioral performance sustainable by the reinforcer at this magnitude, and essential value
of the reinforcer. Figure 1 shows each of these indices and how they relate to the model as a
whole. Note that these indices are not entirely independent of one another. For instance,
Pmax and Omax necessarily correspond to the same unit cost on the demand curve, as the
point of unitary elasticity is always where maximal behavioral output is predicted, although
different levels of responding between conditions that yield a similar Pmax can be observed.
In the same vein, both Pmax and a represent elements of elasticity of demand, that is, the
point of unitary elasticity and the rate of change in elasticity of demand, respectively.
Therefore, we urge caution in interpreting these indices as representing independent
elements of the construct of reinforcement value. Rather, these indices represent elements
that differentially represent different facets of value that may or may not co-vary with each
other in differing degrees. Most importantly, the application of an economic demand model
provides a method to quantifiably compare the value of alternative rewards, or of the same
reward under differing conditions, along a variety of indices.
The aim of the present experiment was to extend previous research on the reinforcement-
enhancing effects of nicotine by applying an economic demand approach to quantifiably
compare the performance of rats responding for VS between conditions of noncontingent
administration of saline or nicotine. The present experiment aimed to provide an insight into
the following questions: (a) Is the conclusion that nicotine changes the reinforcement value
of other stimuli supported using different measures of response strength? (b) Does nicotine
differentially affect different aspects of the behavioral performance (i.e. intensity,
persistence and flexibility) to produce its response-enhancing effects? (c) Does the
application of an economic demand approach provide a more informative analysis for
assessing changes in reinforcement value in the case of the reward-enhancing effects of
drugs?
Methods
Subjects
Sixteen male Sprague–Dawley rats (Harlan, Indianapolis, Indiana, USA), weighing 296 g on
average (±5.6 SEM), were individually housed in clear polycarbonate tubs lined with wood
shavings in a temperature-controlled and humidity-controlled colony. Water was
continuously available in the home cage. Rats were provided 20–25 g of laboratory chow
daily; previous studies from this lab have shown that rats maintain healthy rates of growth
while still encouraging exploratory behavior under these feeding conditions. Sessions were
conducted during the light phase of an automated 12 : 12 h light/dark cycle. Experimental
protocols were approved by the University of Nebraska-Lincoln IACUC and follow the
‘Guide for the Care and Use of Laboratory Animals’ (National Research Council, 1996).
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Apparatus
Sessions were conducted in eight behavioral conditioning chambers (ENV-008CT; Med
Associates Inc., St. Albans, Vermont, USA); measuring 30.5×24.1×21.0 cm (l×w×h)
enclosed in light-attenuating and sound-attenuating cubicles fitted with a fan to mask noise
and provide airflow. Sidewalls were aluminum; the ceiling and front and back walls were
clear polycarbonate. One sidewall featured a dipper receptacle, occupying a 5.2×5.2×3.8 cm
(h×w×d) recessed space, into which a dipper arm, when raised, provided access to 0.1 ml of
a 26% sucrose solution (w/v) in the receptacle. Retractable operant response levers were
located on either side of the dipper receptacle ~5 cm from the chamber floor. Each lever
required 147nN of force for the microswitch close and the computer to record a response.
White 28 V, 100-mA DC lamps were located 7 cm above each lever, hereafter referred to as
the right and left lever lights. Two external 28 V, 100-mA DC lamps were also located 10
cm above the conditioning chamber but within the light-attenuating and sound-attenuating
cubicle, hereafter referred to as the houselight. An infrared emitter/detector unit positioned 4
cm above the rod floor bisected the chamber 14.5 cm from the sidewall featuring the dipper
receptacle and functioned to monitor locomotor activity during experimental sessions. Data
collection and presentation of experimental events were controlled through a personal
computer with Med Associates interface and software (MedPC for Windows, IV) located in
the same room as the conditioning chambers.
Drugs
(−)Nicotine hydrogen tartrate (Sigma, St Louis, Missouri, USA) was dissolved in 0.9%
saline and adjusted to a pH of 7.0±0.2 with a dilute NaOH solution. Nicotine was injected
subcutaneously as 0.4mg base/kg at a volume of 1 ml/kg. Saline was also injected
subcutaneously at a volume of 1 ml/kg.
Habituation and lever training
All rats were habituated to the conditioning chambers and trained to lever press for sucrose
deliveries over four daily 60-min sessions. These sessions delivered a non-contingent 4-s
access to a 26% sucrose solution (w/v) on a variable time (VT) schedule. In addition,
sucrose deliveries were available contingent upon lever pressing on a FR1 schedule on either
lever. To ensure equal exposure to reinforcement on each lever, both levers were presented
at session initiation and the first press on either lever retracted that lever until a response was
made on the opposite lever, resulting in the reintroduction of the former lever and retraction
of the latter. The VTschedule controlling noncontingent sucrose deliveries was faded out
across the four training sessions in the following sequence: VT 45 s; VT 90 s; VT 180 s; and
no VT (all sucrose deliveries were response contingent). These sessions were conducted
with constant houselight illumination. Following the fourth session of lever training, no
sucrose was available at any time for the rest of the experiment.
On the day following the fourth session of lever training/ habituation, rats received training
to press the active lever for a 1-min VS. The VS consisted of a 5-s presentation of the right
and left lever lights concurrent with a 60-s termination of otherwise constant houselight
illumination. This stimulus arrangement resembles that used in previous experiments
examining the reinforcement-enhancing effects of nicotine and has been shown to be weakly
reinforcing (Donny et al., 2003; Palmatier et al., 2006; Chaudhri et al., 2007). Assignment
of levers as active or inactive was randomized and counter-balanced across rats. Responding
on the inactive lever was recorded, but had no programmed consequences. Presentations of
the VS were programmed on a FR1 schedule across the 10 sessions. To habituate the rats to
the injection protocol, and to reduce the initial response-suppressing effects of nicotine, all
rats received an injection of 0.4 mg/kg nicotine 15 min after the completion of each
experimental session during this training period.
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Demand curve determination
Following the VS-training period, VS presentations were provided on a FR schedule for
responses on the active lever over blocks of 10 sessions, each session lasting 60 min. During
these sessions, rats received 0.4 mg/kg nicotine or saline 5 min before placement in the
chambers. Sessions were arranged such that each rat experienced five nicotine and five
saline sessions per 10-session block, in a pseudorandomized order, with no more than two
sessions of each type in succession. Session order was constrained such that on any given
day, half the rats received saline whereas the remainder received nicotine before the session.
Each rat also received the opposite injection 15min following each session, ensuring that
each rat received each injection type daily. The response requirement per VS presentation on
the active lever was escalated across blocks of 10 sessions using the following sequence: 1,
2, 4, 8, 14, 22, and 32.
Drugs
(−)Nicotine hydrogen tartrate (Sigma) was dissolved in 0.9% saline and adjusted to a pH of
7.0±0.2 with a dilute NaOH solution. Nicotine was injected subcutaneously as 0.4 mg base/
kg at a volume of 1 ml/kg. Saline was also injected subcutaneously at a volume of 1 ml/kg.
Data analysis
Data were organized and analyzed using the Microsoft Excel 2007 (Microsoft, Redmond,
Washington, USA), GraphPad Prism 5 (GraphPad Software Inc., La Holla, California,
USA), and SPSS 19 software packages (IBM, Armonk, New York, USA). Only data from
the last three nicotine and the last three saline sessions of each block were analyzed to more
accurately represent stable performance under each reinforcement schedule. Although the
main objective of the present study was to evaluate the effects of nicotine in the behavioral
economic demand model, the data were also analyzed using more traditional measures of
response strength and reinforcement value to provide adequate comparison. To this end, the
total responses made on each lever, the number of VS presentations earned, and locomotor
activity were analyzed using repeated-measures analysis of variance (ANOVA) across
sessions and across FR schedules. All post-hoc analyses were carried out using Fisher’s
least-significant difference (reported as minimum mean differences; LSDmmd).
Data from each FR schedule were averaged across the three nicotine or three saline sessions
for each rat and demand for the VS was assessed under conditions of nicotine and saline
administration by fitting the demand model developed by Hursh and Silberberg (2008) to the
data of each rat [Eq. (1)]. Paired t-tests were used to evaluate the significance in differences
between nicotine and saline conditions for Q0, a, Pmax, and Omax.
Analysis of the demand curves was also carried out following the normalization method
proposed by Hursh and Silberberg (2008). This method normalizes consumption as a
proportion of maximal consumption (Q/Q0) and standardizes price as the total cost required
to maintain Q0 at each response requirement (Q0×C). The utility of this technique is that it
allows for simple comparisons between conditions where consumption and elasticity are
dependent on the scalar properties of the reinforcer (i.e. magnitude, amount, dose); when
this is the case, the demand curves will converge on top of each other and model estimates
will be similar (Hursh and Silberberg, 2008).
Results
All 16 rats acquired lever pressing by the end of the fourth session of habituation and lever-
training session, earning on average 59.8 (±6.84 SEM) sucrose deliveries a session. Over the
following 10-session VS-training period, lever pressing decreased initially, but eventually
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stabilized, with a successful discrimination between active and inactive levers emerging
after the third session (data not shown). The two-way repeated-measures ANOVA (Lever
×Sessions) showed significant main effects of Lever [F(1, 135)=23.13, P<0.001] and
Sessions [F(9, 135)= 19.26, P<0.001], but no significant interaction [F(9, 135)= 1.49, NS].
Figure 2 shows the number of VS presentations earned as a function of unit cost (response
requirement) for all rats across the 70-session demand-assessment period, between nicotine
and saline pretreatment conditions. Rats earned more VS presentations when pretreated with
0.4 mg/kg nicotine than when administered saline across all response requirements. The
three-way repeated-measures ANOVA (Drug×Cost×Sessions) showed significant main
effects of Drug [F(1, 180)=229.8, P<0.001] and of Cost [F(6, 180)=91.64, P<0.001], but not
of Sessions [F(2, 180)=2.93, P=0.069]. A significant Drug×Cost interaction was also found
[F(6, 180)=26.23, P<0.001]. Post-hoc analyses showed a greater effect of response
requirement under saline conditions than under nicotine conditions, and significant
differences in VS presentations earned at every unit cost assessed (LSDmmd=2.21). The
Drug×Sessions interaction was also significant [F(2, 180)=4.70, P<0.02]. Post-hoc analysis
showed that VS presentations earned during the first session were significantly lower than
during the two following sessions only under the nicotine condition (LSDmmd=0.833).
Neither the Cost×Sessions interaction nor the Drug×Cost×Sessions interaction were
significant (P’s ≥ 0.065).
Active lever-pressing data (not shown) followed a trend similar to that of VS presentations
earned: higher levels of lever pressing were observed following pretreatment with 0.4mg/kg
nicotine than saline across all response requirements tested. A three-way repeated-measures
ANOVA (Drug×Cost×Sessions) of active lever pressing showed significant main effects of
Drug [F(1, 180)=130.6, P<0.001] and of Cost [F(6, 180)=13.23, P<0.001], but not of
Sessions (F<1). A significant Drug×Cost interaction was also found [F(6, 180)=20.54,
P<0.001]. Post-hoc analyses showed a greater effect of cost under the saline condition than
under the nicotine condition, and significant differences in active lever pressing across all
unit costs tested (LSDmmd=28.51). Neither the Drug×Sessions, Sessions×Cost, nor
Drug×Cost×Sessions interactions were significant (P’s ≥ 0.497).
Inactive lever pressing (not shown) followed a considerably different trend compared with
VS presentations earned and active lever pressing. Low levels of inactive lever pressing
were observed across response requirements and drug-administration conditions (15.1±1.37
SEM), with a tendency toward higher levels of inactive lever pressing following nicotine
administration than saline. Closer analysis of the inactive lever pressing data (Drug×Cost
×Sessions) indicated a significant main effect of Drug [F(1, 180)=47.02, P<0.001] but not of
Cost [F(6, 180)=1.27, NS] or of Sessions [F<1]. A significant Drug×Cost interaction was
also found [F(6, 180)=4.65, P<0.001]. Post-hoc analyses showed that inactive lever pressing
increased marginally with response requirement and this increase was greater under the
nicotine condition than under the saline condition. Levels of inactive lever pressing were
significantly different between nicotine and saline conditions at every response requirement
tested except FR1 (LSDmmd=5.64).
Locomotor activity (not shown) showed no trends across response requirement or across
sessions within blocks of response requirements, but was consistently higher following
nicotine administration than after saline administration. A repeated-measure three-way
ANOVA (Drug ×Cost×Sessions) of the locomotor activity data indicated a significant main
effect of Drug [F(1, 180)= 145.5, P<0.001], with nicotine pretreatment inducing greater
levels of locomotor activity than saline. No other significant main effects or interactions
were found for locomotor activity (P’s ≥ 0.146).
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As detailed earlier, the reinforcer demand model was fit to the data of individual rats and
estimates of the values of Q0, a, Pmax, and Omax were calculated from the model for each rat
between nicotine and saline conditions (Fig. 3). Because the model cannot accommodate
zero values at a given unit cost, the lowest possible nonzero value under the present test
conditions (0.3333; i.e. 1 VS presentation over 3 days) was substituted in these instances.
The model fits the data well for both the nicotine (R2=0.986) and the saline conditions
(R2=0.996). Table 1 presents the estimates of the aforementioned model parameters for each
rat, between drug conditions. Significant differences were found between drug conditions
for each parameter: Q0, Pmax, and Omax [t’s(15) ≥ 7.54, P<0.001] were higher under
nicotine conditions than under saline conditions, and a was lower for nicotine than for saline
conditions [t(15)=7.62, P<0.001].
Discussion
The present study found that nicotine administration increased operant lever pressing for a
VS, similar to previously reported results (Donny et al., 2003; Chaudhri et al., 2006a; Raiff
and Dallery, 2006, 2009; Caggiula et al., 2009). Importantly, the present results extend
previous findings by systematically evaluating the reward-enhancing effects across a range
of reinforcement schedules and by using a reinforcer demand model to quantify the
differences between the behavioral performance under differing drug conditions. The
finding that nicotine enhanced responding for the VS across the entire range of
reinforcement schedules supports the notion that nicotine increases the reinforcement value
of the VS (cf. Chaudhri et al., 2006a, 2006b). However, nicotine did not uniformly increase
lever pressing for the VS across each response requirement tested. Rather, the magnitude of
this effect varied with the changes in unit cost. Interestingly, nicotine increased responding
for the VS at unit costs at which responding under saline was almost abolished (FR22 and
FR32).
The advantage of the behavioral economic approach adopted for the present study (cf. Hursh
and Silberberg, 2008) is that it allows us to quantifiably compare different aspects of the
operant performance across response requirements. These include the intensity of demand
for the reinforcer when it costs nothing (Q0), persistence of responding for the reinforcer
(Pmax), the maximal behavior output maintained by the reinforcer (Omax), and the essential
value of the reinforcer after accounting for sensitivity to changes in unit cost (a). Previous
studies have shown that these parameters may vary independently and represent different
facets of reinforcement value [for a review, see Hursh and Silberberg (2008)]. For example,
Hursh and Winger (1995) showed how scalar differences in consumption resulting from
variations in reinforcer magnitude can differentially affect different parameters of the
reinforcedemand equation. Briefly, adult rhesus monkeys were trained to self-administer
intravenous infusions of alfentanil at doses of 0.0003, 0.001, 0.003, and 0.01 mg/kg, and
demand curves were generated from performance across a range of FR schedules (Hursh and
Winger, 1995; Winger et al., 1996). Analysis of the demand curves showed large differences
in Q0, Pmax, and Omax between doses of alfentanil, but similar values of a, indicating that
the essential value of the reinforcer remains constant despite large shifts in the levels of
consumption of the reinforcer caused by differences in reinforcer magnitude. In support of
this conclusion, when the demand curves for alfentanil were evaluated after normalizing
consumption as a proportion of Q0 and, normalizing price as the product of response
requirement and Q0, the four demand curves representing each dose of alfentanil converged
on top of each other and values of Pmax and Omax became similar (Hursh and Winger,
1995).
In contrast to Hursh and Winger (1995), in the present study, we observed differences in all
four model estimates. This outcome indicates that the differences observed in the present
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study are not because of changes in the perceived reinforcing magnitude of the VS generated
by nicotine administration. Figure 4 graphically demonstrates this point by showing the
resultant demand curves after applying the same normalizing operations on consumption and
price proposed in previous studies (Hursh and Winger, 1995; Hursh and Silberberg, 2008).
The curves generated under nicotine and saline conditions do not converge, nor do the
estimates of Pmax and Omax become similar, suggesting that the observed enhancement of
responding by nicotine in the present study does not reflect a scalar enhancement of the
perceived magnitude of the reinforcing VS that is analogous to changes in drug dose.
The present findings support previous claims that nicotine enhances the strength of other
reinforcing stimuli through nonassociative means. Note that this entire study was carried out
within subjects, and that the data comprising the nicotine and saline demand curves come
from the same rats receiving nicotine or saline pretreatment in a pseudo-alternating manner
across sessions. Such a procedure is unlikely to engender effective conditioning between the
VS and the nicotine stimulus because both VS and nicotine were delivered in the absence of
one another during half the sessions (i.e. the saline pretreatment sessions). The finding that
nicotine reliably enhanced lever pressing above levels observed following saline
administration supports this assumption. The present findings, combined with previously
published reports from other laboratories (see the Introduction section), provide strong
evidence against the suggestion that a purely associative learning process is responsible for
the reward-enhancing effects of nicotine. Furthermore, the present results are equally
difficult to explain from the perspective of lasting neuronal changes resulting from repeated
nicotine exposure that exert their effects in the absence of nicotine. That is, nicotine
exposure alone is inadequate to account for the present findings because we do not observe
reliable increases in levels of operant responding for the VS merely as a function of sessions
and nicotine experience during saline sessions.
An alternative interpretation of the present results relies on the well-documented and reliable
effect of nicotine exposure to increase baseline rates of locomotor activity (Bevins and
Besheer, 2001; Bevins et al., 2001; Frenk and Dar, 2004). Indeed, such an account makes
several studies on the reward-enhancing effects of nicotine harder to interpret, especially
when one considers the possible interaction of locomotor-stimulating effects and learned
place-preference within the experimental apparatus centered around the operandum that
produces reinforcement. That is, rats may possibly develop a preference for the spatial
location they previously occupied at the time of reinforcement delivery, and any locomotor-
activating effects of nicotine may be disproportionately expressed within that same spatial
location. Because this location is shared by the active lever, locomotor-activating effects by
nicotine may reveal themselves as more responding on that lever. Although the present
study does not systematically examine this issue, and thus cannot directly refute its
plausibility, there are several observations that make a locomotor-activation account alone
inadequate. First, initial lever training with liquid sucrose was arranged to force equal
experience with both levers producing reward, reducing the likelihood of rats developing a
preference for one lever over the other before VS-lever training. Further, the observed
differences in locomotor activity between nicotine and saline sessions did not vary
systematically with increases in the response requirement for the VS. Although increases in
inactive lever pressing occurred with increases in response cost, these increases were
observed under both nicotine and saline conditions, and were only marginally higher on
nicotine sessions. Moreover, although an effect of nicotine on general chamber locomotor
activation (i.e. center beam breaks) was observed in the present experiment, this effect did
not vary across sessions or as a function of response cost. These findings, in combination
with previous findings from other laboratories (cf. Donny et al., 2003; Chaudhri et al.,
2006a, 2006b; Palmatier et al., 2006; Raiff and Dallery, 2006, 2009; Barrett and Odum,
2011; Cassidy and Dallery, 2012), indicate that the locomotor-activating effects of nicotine
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are a minor contributor, at best, toward the enhancement in operant responding observed in
the present experiment. For example, Raiff and Dallery (2008) found that although nicotine
administration did lead to an increase in the response rates for conditioned reinforcers in an
observing response procedure, nicotine exerted no effects of food-maintained responding.
Furthermore, nicotine did not lead to an increase in the rates of response associated with
either conditioned or unconditioned reinforcement during extinction, suggesting that the
enhancement in operant responding by nicotine is not adequately explained as a tendency to
increase responding that has been reinforced in the past (Frenk and Dar, 2004). Rather, the
present results are more consistent with a reward-enhancement account of the effects of
nicotine on operant responding, but do not rule out possible contributions from the
locomotor-activating effects of nicotine.
The present study provides a method for evaluating the reward-enhancing effects of
compounds using a behavioral economic reinforcer demand approach. Although the
individual estimates of Q0, Pmax, Omax, and a did not yield results that differed in
interpretation in the present study, which does not preclude their utility in evaluating the
specific effects of compounds on different facets of reinforcement value in future studies.
For instance, the mechanisms by which nicotine exerts its reward-enhancing effects remain
unclear, as also how these mechanisms differ from those underlying the primary reinforcing
effects of nicotine. Nicotine acts on several receptor subtypes in the cholinergic system, in
addition to exerting modulating effects on other receptor systems (Brunzell and Picciotto,
2009). Some of these receptor subtypes or modulatory roles may have differential effects on
the various facets of reinforcer value, and these may be reflected in differences between
specific model estimates. Although such a conjecture at this point is certainly speculative,
using a methodology that has the ability to detect such differences is favorable to using one
that lacks this capability. Furthermore, the present results and methodology provide a far
richer picture of the reward-enhancing effects of nicotine by virtue of the repeated
assessment across a wide range of reinforcement schedules under multiple conditions, and
provides a technique for quantifiably comparing differences in performance along multiple
indices that represent different facets of reinforcement value.
Several questions remain on the nature of the reward-enhancing effects of nicotine for future
studies to investigate. The present study will hopefully provide a powerful procedure for
examining these questions. For instance, previous work has shown that the reward-
enhancing effects of nicotine depend, in part, upon the degree of initial reinforcement value
of the stimulus to be enhanced (Palmatier et al., 2007). The reinforcer demand procedure
used in the present study provides a novel approach toward quantifiably investigating this
effect. The reinforcer demand approach is unique by allowing the investigator to compare
rates of reinforcement across a range of response requirements between conditions where
the reinforcer differs in initial value. The estimates of the model allow for the possibility of
detecting differences in intensity of demand for the reinforcer, persistence of responding for
the reinforcer, maximal behavioral output generated by the reinforcer, and essential value of
the reinforcer, which may vary independently between conditions. Our hope is that the
application of such an approach may enrich the knowledge that we currently possess on
what appears to be an important piece of the puzzle of nicotine reward, leading to a better
understanding of tobacco addiction and informing better treatment procedures.
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Fig. 1.
Hypothetical data representing two typical demand curves plotted as the number of
reinforcers earned as a function of fixed-ratio schedule (unit cost). The effects of
experimental condition on the models estimates of Q0, Pmax, Omax, and a are shown.
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Fig. 2.
Number of visual stimulus presentations earned between nicotine and saline administration
conditions as a function of fixed-ratio schedule (unit cost). The filled and open circles
represent data from the nicotine and saline administration sessions, respectively, averaged
over the last three sessions of each type. The solid and dashed lines represent the predicted
values of the reinforcer demand model when fit to the mean data from the nicotine and
saline conditions, respectively. Note that both axes are plotted in logarithmic space.
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Fig. 3.
Values for the model estimates of Q0, a, Pmax, and Omax between nicotine and saline
conditions from fits of the model to the data from individual rats. The solid circles (left) and
open circles (right) represent the data from nicotine and saline administration sessions,
respectively. Q0 is represented in units of visual stimulus presentations earned. Pmax and
Omax are represented in the number of lever presses. a is represented in arbitrary units and is
inversely correlated with reinforcer value.
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Fig. 4.
Demand curves from the mean normalized data expressed as normalized consumption as a
function of normalized price. Normalized consumption was calculated as the number of
visual stimulus presentations earned divided by Q0. Normalized price was calculated as the
product of response requirement and Q0. Filled and open circles represent the data from the
nicotine and the saline sessions, respectively.
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